Antiarrhythmic Actions of Amiodarone: A Profile of a Paradoxical Agent

This publication has 56 references indexed in Scilit:

• The Coming of Age of the Class III Antiarrhythmic Principle: Retrospective and Future Trends
  The American Journal of Cardiology, 1996
• Randomized, Double-Blind Comparison of Intravenous Amiodarone and Bretylium in the Treatment of Patients With Recurrent, Hemodynamically Destabilizing Ventricular Tachycardia or Fibrillation
  Circulation, 1995
• Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias
  Circulation, 1995
• Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction
  The American Journal of Cardiology, 1990
• Electrophysiologic effects of amiodarone: Experimental and clinical observation relative to serum and tissue drug concentrations
  American Heart Journal, 1984
• Amiodarone: Historical development and pharmacologic profile
  American Heart Journal, 1983
• Clinical efficacy of amiodarone as an antiarrhythmic agent
  The American Journal of Cardiology, 1976
• Effects of amiodarone on thyroid function in patients with ischaemic heart disease.
  Heart, 1975
• Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride
  The American Journal of Cardiology, 1974
• The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle
  British Journal of Pharmacology, 1970